title: Clinical analysis of submucosal Medpor implantation for empty nose syndrome.
abstract: Empty nose syndrome (ENS) describes symptomatology and radiographic findings after surgeries on turbinates.The treatment of ENS is still debatable.
  
  
  
  To analyse clinical outcomes of submucosal Medpor® implantation for ENS.
  
  
  
  A total of 18 patients underwent submucosal Medpor® implantation from 2006 to 2011. We applied SNOT-22 (SinoNasalOutcome Test) for statistical survey of the patients' symptoms before and after surgery.
  
  
  
  Two patients were lost to follow up after the surgery. Most of the patients developed ENS-related symptoms gradually within 2 years to 16 years after the previous nasal surgery or treatment. The sites of submucosal implantation are mainly septum and nasal floor, unilaterally or bilaterally. There is a significant improvement of SNOT-22 pre-operatively to one year post-operatively.
  
  
  
  The symptomatolgy remains the most important point when dealing with patients with ENS. Submucosal implantation of Medpor® is a feasible surgical treatment to ENS. A positive cotton test is suggested for the surgical indication and planning.
authors.forename: Y Y
authors.initials: YY
authors.lastname: Tam
authors.forename: T J
authors.initials: TJ
authors.lastname: Lee
authors.forename: C C
authors.initials: CC
authors.lastname: Wu
authors.forename: P H
authors.initials: PH
authors.lastname: Chang
authors.forename: Y W
authors.initials: YW
authors.lastname: Chen
authors.forename: C H
authors.initials: CH
authors.lastname: Fu
authors.forename: C C
authors.initials: CC
authors.lastname: Huang
mesh_terms: D006801:Humans; D015508:Nasal Obstruction / Q000601:surgery*; D059747:Nasal Surgical Procedures / Q000592:standards; D011095:Polyethylenes; D019919:Prosthesis Implantation / Q000379:methods*; D016896:Treatment Outcome; D014420:Turbinates / Q000601:surgery*
chemical_list: C084562:Medpor; D011095:Polyethylenes